FIELD: biotechnology.
SUBSTANCE: composition is proposed which comprises stem cells of human amniotic fluid with the phenotype CD73+/CD90+/CD105+/CK19+, nutrient medium, erythropoietin, epidermal growth factor, and collagen taken in an effective amount.
EFFECT: invention enables to increase the proliferative potential and viability of the cells, while simultaneously providing cytoprotective effect on the cells of the transplant and stimulation of migration and proliferation of patient's own cells, and also to reduce significantly the concentration of injectable cells and to activate vascularisation and regeneration at the defect site and can be used in therapy for elimination of congenital and acquired defects of soft tissue arising as the result of injuries, after removal of tumors, congenital diseases, age-related changes or other damages.
2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING FROSTBITE USING MESENCHYMAL STEM CELLS ISOLATED FROM RED BONE MARROW | 2020 |
|
RU2748539C1 |
METHOD FOR ISOLATION OF MESENCHYMAL STEM CELLS FROM AMNIOTIC MEMBRANE OF UMBILICAL CORD, USING CELL CULTURAL MEDIUM | 2017 |
|
RU2783992C2 |
RAPID PREPARATION AND USE OF ARTIFICIAL TISSUES AND FRAMES AS INDIVIDUAL IMPLANTS | 2009 |
|
RU2531046C2 |
METHOD FOR NEOGENESIS | 2004 |
|
RU2542391C2 |
TISSUE REGENERATION METHOD | 2004 |
|
RU2392314C2 |
METHOD OF INCREASING EFFICIENCY OF COMBINED THERAPY IN LOCAL RADIATION DAMAGE | 2019 |
|
RU2744519C1 |
AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
STROKE TREATMENT WITH APPLICATION OF ISOLATED PLACENTAL CELLS | 2009 |
|
RU2558778C2 |
BIOMEDICAL COMPOSITION FOR TREATING DEGENERATIVE JOINT DISEASES BASED ON REGIONAL ADULT STEM CELLS | 2018 |
|
RU2708376C1 |
METHOD AND COMPOSITION FOR TISSUE REGENERATION USING STEM OR MARROW CELLS | 2009 |
|
RU2491076C2 |
Authors
Dates
2014-07-20—Published
2013-02-12—Filed